Patent Assignment
Reel/Frame 064899/0307
Assignment of Assignor's Interest
Recorded: 2023-09-14
Pages: 2
Assignor
ONCOVALENT THERAPEUTICS INC.
Executed: 2023-09-13
Assignee
SUVALENT THERAPEUTICS INC.
2101 CORPORATE CENTER DRIVE, SUITE 200, NEWBURY PORT, CALIFORNIA, 91320
Covered Property
(1)
4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine Sumo Inhibitors and Uses Thereof
Application:
17/793,191 →
Publication:
US 2023/0303584
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 17, 2022
From: OUYANG, XIAOHU; KUBOTA, MILES DOUGLAS; TASKER, ANDREW STEWART
To: SUMO BIOSCIENCES INC.
Reel/Frame 061438/0235 →
Assignment of Assignor's Interest
Oct 17, 2022
From: OUYANG, XIAOHU; KUBOTA, MILES DOUGLAS; TASKER, ANDREW STEWART; HONG, FANG-TSAO
To: ONCOVALENT THERAPEUTICS INC.
Reel/Frame 061438/0485 →
Change of Name
Oct 17, 2022
From: SUMO BIOSCIENCES INC.
To: ONCOVALENT THERAPEUTICS INC.
Reel/Frame 061689/0836 →
Assignment of Assignor's Interest
Dec 23, 2025
From: SUVALENT THERAPEUTICS, INC.
To: CIT THERAPEUTICS LLC
Reel/Frame 073303/0442 →
Change of Name
Jun 15, 2026
From: CIT THERAPEUTICS LLC
To: CIT THERAPEUTICS, INC.
Reel/Frame 075871/0801 →